Trasca Diana Maria, Dop Dalia, Stoica George-Alin, Adrian Niculescu Stefan, Carmen Niculescu Elena, Văruț Renata Maria, Singer Cristina Elena
Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Department of Mother and Baby, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Pharmaceuticals (Basel). 2025 Jul 11;18(7):1035. doi: 10.3390/ph18071035.
Diabetes mellitus is a chronic metabolic disease that has a significant impact on public health and is becoming more and more common worldwide. Although effective, conventional therapies are often limited by high cost, adverse effects, and issues with patient compliance. As a result, there is growing interest in complementary and alternative therapies. Medicinal plants have played an essential role in diabetes treatment, especially in regions such as Romania, where biodiversity is high and traditional knowledge is well preserved. The pathophysiology, risk factors, and worldwide burden of diabetes are examined in this review, with an emphasis on the traditional use of medicinal plants for glycemic control. A total of 47 plant species were identified based on ethnopharmacological records and recent biomedical research, including both native flora and widely cultivated species. The bioactive compounds identified, such as flavonoids, triterpenic saponins, polyphenols, and alkaloids, have hypoglycemic effects through diverse mechanisms, including β-cell regeneration, insulin-mimetic action, inhibition of α-glucosidase and α-amylase, and oxidative stress reduction. A systematic literature search was conducted, including in vitro, in vivo, and clinical studies relevant to antidiabetic activity. Among the species reviewed, , , and exhibited the most promising antidiabetic activity based on both preclinical and clinical evidence. Despite promising preclinical results, clinical evidence remains limited, and variability in phytochemical content poses challenges to reproducibility. This review highlights the potential of Romanian medicinal flora as a source of adjunctive therapies in diabetes care and underscores the need for standardization and clinical validation.
糖尿病是一种慢性代谢疾病,对公众健康有重大影响,且在全球范围内日益普遍。尽管传统疗法有效,但往往受到高成本、不良反应和患者依从性问题的限制。因此,人们对补充和替代疗法的兴趣与日俱增。药用植物在糖尿病治疗中发挥了重要作用,尤其是在罗马尼亚等生物多样性高且传统知识保存良好的地区。本综述探讨了糖尿病的病理生理学、危险因素和全球负担,重点关注药用植物在血糖控制方面的传统用途。根据民族药理学记录和近期生物医学研究,共鉴定出47种植物物种,包括本地植物群和广泛种植的物种。所鉴定的生物活性化合物,如黄酮类化合物、三萜皂苷、多酚和生物碱,通过多种机制发挥降血糖作用,包括β细胞再生、胰岛素模拟作用、抑制α-葡萄糖苷酶和α-淀粉酶以及降低氧化应激。进行了系统的文献检索,包括与抗糖尿病活性相关的体外、体内和临床研究。在所综述的物种中,根据临床前和临床证据,[此处原文缺失具体物种名称]表现出最有前景的抗糖尿病活性。尽管临床前结果很有前景,但临床证据仍然有限,植物化学成分的变异性对可重复性构成挑战。本综述强调了罗马尼亚药用植物群作为糖尿病护理辅助疗法来源的潜力,并强调了标准化和临床验证的必要性。